Professional Documents
Culture Documents
AXIS SEC - Hero Motocorp LTD
AXIS SEC - Hero Motocorp LTD
In an ever-changing business environment, some of our investment ideas seem more convincing than
others due to better earning visibility and/or attractive valuation. Every Monday, we bring you such
fundamental stock ideas through our “Pick of the Week” report.
Investment Horizon: Though the ideal investment horizon for such ideas remain 6-9 months, our picks may provide some
Risk-Return Profile: Pick of the week ideas are the best high return research ideas at this point in time.
* Note: Investment horizon Approx. 6-9 months., CMP as on 1st October, 2020
Buy
Pick of the Week Hero Motocorp Limited Target Price
5th October, 2020
Auto
3,450
Hero Motocorp Ltd (HMCL) is the market leader in the 2W industry with a market share of ~39% (as of Aug 2021). Hero is
present in both the motorcycles and the scooter segments, having market share of about ~53% and ~10%, respectively.
Motorcycles form the major chunk of its revenue, contributing about 90% to total volumes, while scooters contribute 10% to
its total volumes. Hero is a domestically focused company deriving about 96% of volumes from the Indian market. Entry-level
motorcycles (75 cc to 110 cc) form a major chunk of about 70% of overall volumes. The company has six plants in India and
CMP Target two international plants: one in Villa Rica, Columbia and the other in Jessore, Bangladesh. Hero has a combined
(Rs) (Rs) manufacturing capacity of 9.1 mn units per annum.
Investment Rationale
3,153 3,450
Sharp recovery in Volumes led by strong Rural demand and upcoming Festive Season: HMCL is in a sweet spot as
strong rural-led recovery plays to its strength in the Economy–Executive category in the Motorcycles segment. With an apt
product portfolio for the rural market, the highest brand recall, and a strong distribution network, it is best placed to benefit
from the ongoing momentum in the rural economy (50% of the company’s domestic volumes is derived from rural India).
Wholesale dispatches for the company are expected to be healthy in the near term given low channel inventory ahead of the
MARKET DATA Festive season. The channel filling to build up inventory will drive volumes in the near term.
Renewed focus on Premium Motorcycles and Scooters: HMCL is working hard towards recovering its lost market share in
No. of Shares : 19.97 cr the Premium Segment as well as the Scooter segment. Hero launched four new models under its Xtreme & XPulse brands
over the year, marking a re-entry in the premium motorcycle segment. Co’s latest offering Xtreme 160R has been well
Market Cap : Rs.62,981 Cr received by the customers. In the scooter segment, the company has launched Destini 125 scooter with start-stop technology
and Maestro Edge 125 scooter.
52-week High / Low : Rs.3,221.6/1,475 Exports: Hero is focusing on growing export markets by concentrating on African, Latin American, & Southeast Asian regions.
Hero has continuously expanded its geographic footprint in export markets, increasing its presence from 29 countries in FY16
BSE Code : 500182 to 40+ countries in FY20. The company would follow market-specific strategies to enhance export volumes going ahead.
Possibility of GST Rate Cut: While there is no clarity on whether the GST cut would actually happen and whether it would
NSE Code : HEROMOTO
be across 2W segments, we do believe that there is a case for GST cuts for commuter segment (100–125cc 2Ws). This
augurs well for HMCL considering >90% of volumes come from <125cc segment (incl. Scooters). HMCL would be the biggest
beneficiary if the GST rate cut goes through.
We recommend to buy with a target price of Rs. 3,450.
Strike rate based on rolling 6 months Strike rate since Jan 2018
POW Cumulative Strike Rate
Pick of Week Strike Rate
70
90
62
81 61 61
58
80 77 78 57 57
60 57 57
73 73 55 54
69 70 51 51 52 52
70 50 50
64 49
62 62 50 46 46
46 45 46
58 58 58 4545
60 4343
54 54 42 42
4039
50 38
40
50 46
44 33
42
38
40 30
35 35
30
20
20
10
10
0 0
Apr-19
May-19
Apr-20
May-20
Aug-19
Nov-19
Aug-20
Jan-19
Feb-19
Jul-19
Sep-19
Feb-20
Jul-20
Sep-20
Dec-18
Mar-19
Jun-19
Dec-19
Jan-20
Mar-20
Jun-20
Oct-19
Jan-19
Jan-20
Mar-18
Jun-18
Oct-18
Mar-19
Jun-19
Oct-19
Mar-20
Jun-20
May-18
May-19
May-20
Apr-18
Aug-18
Nov-18
Apr-19
Aug-19
Nov-19
Apr-20
Aug-20
Feb-18
Jul-18
Sep-18
Feb-19
Jul-19
Sep-19
Feb-20
Jul-20
Sep-20
Dec-18
Dec-19
Note: We have changed our methodology of calculation of strike rates for PoW product from July 2020; and shifted to calculations using 6 months rolling returns method and cumulative basis as against
earlier method of calculating the strike rate for last 9 months. The performance under the revised methodology is as above.
Disclosures:
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
1. Axis Securities Ltd. (ASL) is a SEBI Registered Research Analyst having registration no. INH000000297. ASL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking
services, Depository participant services & distribution of various financial products. ASL is a subsidiary company of Axis Bank Ltd. Axis Bank Ltd. is a listed public company and one of India’s largest private sector bank and has its
various subsidiaries engaged in businesses of Asset management, NBFC, Merchant Banking, Trusteeship, Venture Capital, Stock Broking, the details in respect of which are available on www.axisbank.com.
2. ASL is registered with the Securities & Exchange Board of India (SEBI) for its stock broking & Depository participant business activities and with the Association of Mutual Funds of India (AMFI) for distribution of financial products and
also registered with IRDA as a corporate agent for insurance business activity.
3. ASL has no material adverse disciplinary history as on the date of publication of this report.
4. I/We, authors (Research team) and the name/s subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect my/our views about the subject issuer(s) or securities. I/We (Research
Analyst) also certify that no part of my/our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. I/we or my/our relative or ASL or its Associate does not have any
financial interest in the subject company. Also I/we or my/our relative or ASL or its Associates may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of
publication of the Research Report. Since associates of ASL are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject
company/companies mentioned in this report. I/we or my/our relative or ASL or its associate does not have any material conflict of interest. I/we have not served as director / officer, etc. in the subject company in the last 12-month
period.
Sr. No Name Designation E-mail
1 Naveen Kulkarni Chief Investment Officer [email protected]
2 Pankaj Bobade Research Analyst – (Research Head) [email protected]
3 Neeraj Chadawar Quantitative Head [email protected]
4 Suvarna Joshi Research Analyst [email protected]
5 Siji Philip Research Analyst [email protected]
6 Omkar Tanksale Research Analyst [email protected]
7 Uttamkumar Srimal Research Analyst [email protected]
8 Ankush Mahajan Research Analyst [email protected]
9 Gaurav Uttrani Research Analyst [email protected]
10 Dnyanada Vaidya Research Analyst [email protected]
11 Hiren Trivedi Research Associate [email protected]
12 Darshan Gangar Research Associate [email protected]
13 Tanvi Shetty Research Associate [email protected]
5. ASL or its Associates has not received any compensation from the subject company in the past twelve months. I/We or ASL or its Associate has not been engaged in market making activity for the subject company.
6. In the last 12-month period ending on the last day of the month immediately preceding the date of publication of this research report, ASL or any of its associates may have:
i. Received compensation for investment banking, merchant banking or stock broking services or for any other services from the subject company of this research report and / or;
ii. Managed or co-managed public offering of the securities from the subject company of this research report and / or;
iii. Received compensation for products or services other than investment banking, merchant banking or stock broking services from the subject company of this research report;
ASL or any of its associates have not received compensation or other benefits from the subject company of this research report or any other third-party in connection with this report.
Term& Conditions:
This report has been prepared by ASL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to, copied or
distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ASL. The report is based on the facts, figures and information that are considered true, correct, reliable and
accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been independently verified and no
guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report is prepared solely for informational
purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the customers simultaneously, not all customers
may receive this report at the same time. ASL will not treat recipients as customers by virtue of their receiving this report.
Disclaimer:
Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to the recipient’s specific circumstances. The
securities and strategies discussed and opinions expressed, if any, in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment
objectives, financial positions and needs of specific recipient.
This report may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this report should make such investigations as it deems necessary to arrive at an
independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved), and should consult its own advisors to determine the merits and
risks of such an investment. Certain transactions, including those involving futures, options and other derivatives as well as non-investment grade securities involve substantial risk and are not suitable for
all investors. ASL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on
basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. Past
performance is not necessarily a guide to future performance. Investors are advice necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the
risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to
change without notice.
ASL and its affiliated companies, their directors and employees may; (a) from time to time, have long or short position(s) in, and buy or sell the securities of the company(ies) mentioned herein or (b) be
engaged in any other transaction involving such securities or earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an
advisor or investment banker, lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
Each of these entities functions as a separate, distinct and independent of each other. The recipient should take this into account before interpreting this document. The Research reports are also available
& published on AxisDirect website.
ASL and / or its affiliates do and seek to do business including investment banking with companies covered in its research reports. As a result, the recipients of this report should be aware that ASL may
have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based on any specific merchant banking, investment banking or brokerage service
transactions. ASL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
Neither this report nor any copy of it may be taken or transmitted into the United State (to U.S. Persons), Canada, or Japan or distributed, directly or indirectly, in the United States or Canada or distributed
or redistributed in Japan or to any resident thereof. If this report is inadvertently sent or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention
of the sender. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such
distribution, publication, availability or use would be contrary to law, regulation or which would subject ASL to any registration or licensing requirement within such jurisdiction. The securities described
herein may or may not be eligible for sale in all jurisdictions or to certain category of investors.
The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. The
Company reserves the right to make modifications and alternations to this document as may be required from time to time without any prior notice. The views expressed are those of the analyst(s) and the
Company may or may not subscribe to all the views expressed therein. Copyright in this document vests with Axis Securities Limited.
Axis Securities Limited, Corporate office: Unit No. 2, Phoenix Market City, 15, LBS Road, Near Kamani Junction, Kurla (west), Mumbai-400070, Tel No. – 18002100808/022-61480808, Regd. off.- Axis
House, 8th Floor, Wadia International Centre, Pandurang Budhkar Marg, Worli, Mumbai – 400 025. Compliance Officer: Anand Shaha, Email: [email protected], Tel No: 022-42671582.
SEBI-Portfolio Manager Reg. No. INP000000654